RAFAEL HOLDINGS, INC. Deferred Federal Income Tax Expense (Benefit)
RAFAEL HOLDINGS, INC. (RFL) reported Deferred Federal Income Tax Expense (Benefit) of -$160.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. deferred federal income tax expense (benefit) for fiscal 2025 was -$160.00K.
- RAFAEL HOLDINGS, INC. deferred federal income tax expense (benefit) for fiscal 2024 was -$17.00K.
- RAFAEL HOLDINGS, INC. deferred federal income tax expense (benefit) for fiscal 2018 was $8.22M, a 2804.24% increase from fiscal 2017.
- RAFAEL HOLDINGS, INC. deferred federal income tax expense (benefit) for fiscal 2017 was $283.00K, a 30.81% decline from fiscal 2016.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-07-31 | -$160.00K 10-K · filed 2025-10-29 |
| 2024-07-31 | -$17.00K 10-K · filed 2025-10-29 |
| 2018-07-31 | $8.22M 10-K · filed 2019-10-04 |
| 2017-07-31 | $283.00K 10-K · filed 2018-10-15 |
| 2016-07-31 | $409.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |